ALFA FinderBSE filing, NSE: SPML. Summary written from the filing by ALFA Finder's alert engine.
Speciality Medicines Ltd: key numbers
- Share price
- ₹161.00
- Market cap
- ₹141.4 Cr
- Revenue (annual)
- ₹75.29 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 10.8×Sector 43.8×
- Promoter holding
- 43.43%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Speciality Medicines Ltd
All →Speciality Medicines Other Announcement
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited conducted its 5th Annual General Meeting on September 28, 2026. Shareholders considered the adoption of FY26 audited financial statements and the re-appointment of Director Sumit Goyani.
Speciality Medicines Annual Report
Speciality Medicines Limited has submitted its Annual Report for the financial year 2025-26 to the exchange, complying with regulatory filing requirements.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited scheduled its 5th Annual General Meeting for September 28, 2026. The board also approved the draft Directors' Report for FY 2025-26.
Speciality Medicines Regulatory Approval
Speciality Medicines Limited received regulatory approval in Ethiopia for two additional pharmaceutical formulations, Olanzapine and Diazepam tablets. The company now has 12 registered products in Ethiopia.
Speciality Medicines Business Update
Speciality Medicines Limited received regulatory approval for two new products, Olanzapine and Diazepam tablets, in the Ethiopian market, strengthening its international export portfolio.
Other board meeting date announcements
All →Associated Ceramics Board Meeting Date
Associated Ceramics has scheduled a board meeting on November 14, 2026 to consider unaudited standalone September 2026 half-yearly results. Advance notice; meeting not yet held.
Dudani Retail Board Meeting Date
Dudani Retail has given intimation of a board meeting on 14 November 2026 to consider unaudited half-year standalone results and related statements. The trading window stays closed until 48 hours after the results are declared.
Davin Sons Retail Board Meeting Date
Davin Sons Retail will hold a board meeting on 14 November 2026 to consider half-year results and a registered office shift. No amount is stated.
Shine Fashions (India) Board Meeting Date
Shine Fashions (India) has given prior intimation of a board meeting on 14 November 2026 to consider half-year results and a preferential fund raise. Trading window has been closed since 1 October 2026.
Gautam Exim Board Meeting Date
Gauam Exim will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 30 November 2026, having opened 1 November 2026.
Sollfege Smart Electronics Board Meeting Date
Sollfege Smart Electronics will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 8 to 15 November 2026.